Medplus Health Services Ltd. · NSE:MEDPLUS
Medplus Health Services — Q3 FY2022 Earnings Presentation
24 slides from Medplus Health Services's earnings presentation, Feb 15, 2022
Slide 1: Financial Results Presentation filing letter to exchanges
MedPlus Health Services Limited Date: 15t February, 2022 BSE Limited National Stock Excharige of India Limited Phiroze Jeejebhoy Towers, Exchange Plaza , 5 Floor Dalal Street, Fort, Plot No. C/1, G Block, Mumbai - 400001 Bandra - Kurla Complex Bandra (East), Mumbai - 400051 Dear Sir/ Madam, Sub: Fin
Slide 2: Third Quarter FY2022 Investor Presentation
THIRD QUARTER FY2022 INVESTOR PRESENTATION Corporate information Performance update Financial results FEBRUARY 2022
Slide 3: Safe Harbour
Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by MedPlus Health Services Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for
Slide 4: MedPlus – Leader In The Attractive Pharmacy Space
MedPlus – Leader In The Attractive Pharmacy Space Overview Fastest Growing Retail Segment Large Headroom to Grow 30% Pharmacy 25% 25% Food & Grocery 22% Jewellery 21% 20% Apparel 16% 16% 0% 20% 40% 60% 80% 100% 15% 14% Organized Retail Unorganized 10% 8% Better Unit Economics 5% Pharmacy: High reven
Slide 5: The MedPlus Story
The MedPlus Story Overview MedPlus caters to the healthcare and 2006 16 years c.750m+ household needs of Started in Hyderabad A Trusted Brand Bills Cut Since Inception the neighborhoods we operate in We are omni- 2,477 stores 7 280 channel: Digital and Stores States Cities neighborhood stores MedPlu
Slide 6: Cluster Based Network Enables Profitable Omni-Channel Service
Cluster Based Network Enables Profitable Omni-Channel Service Overview Stores As On Dec-21 Strong Cluster Based Network Strong network of 2,477 stores across Metros, Tier-One, Tier-Two and beyond. 2,477 stores 2- hour delivery Ability to service 100% market – acute + chronic Online only players cann
Slide 7: Scale Allows A Large Private Label Basket: 800+ SKUs
Scale Allows A Large Private Label Basket: 800+ SKUs Overview Pharma and Related Non-Pharma Pharma Over 558 products covering Chronic, Acute, OTC & Other Pharmaceutical products Non-Pharma Over 252 products covering, packaged food, baked goods, dry goods, cleaning products, cosmetics and toiletries
Slide 8: Poised for Growth
Poised for Growth Overview Key Pillars Of Growth Financial Capacity • Further grow in cities where we have market leadership. Metro and Tier - Operating Cash Flow Growth in existing clusters and One followed by Tier - Two and beyond A 1 develop new clusters • Replicate our leadership in markets ₹ 27
Slide 9: Q3 FY2022 Highlights (1/2)
Results Update Q3 FY2022 Highlights (1/2) ₹ 9,335m Revenue ₹ 1,938m Gross Margin • ₹ 1,325m increase vs. Q3FY21. 16.5% • 20.8% gross margin (+0.6% yoy, yoy +0.7% qoq) • ₹ 87m increase vs. Q2FY22. 0.9% qoq • 11.9% private label (+2.0% yoy) 151 Store Net Additions 4.2% yoy: Stores > 12 months • 183 gr
Slide 10: Q3 FY2022 Highlights (2/2)
Results Update Q3 FY2022 Highlights (2/2) Revenue, ₹m EBITDA and Operating EBITDA, ₹m 16.5% 9,552 1,007 9,335 9,247 704 689 688 670 647 8,010 8,057 410 383 374 366 Gross 20.1% 20.5% 22.1% 20.1% 20.8% Operating 5.1% 4.8% 7.4% 4.0% 3.9% Margin EBITDA Margin EBITDA Operating EBITDA 8
Slide 11: Stores Added In Last Months
Results Update 537 Stores Added In Last 12 Months As On Dec-20 As On Sep-21 As On Dec-21 Presence 1,940 2,326 2,477 We are present in stores stores stores key 7 states, accounting for c.38.4% of India’s population2. The key urban centers are: Bangalore, Chennai, Hyderabad, Kolkata, Mumbai, Nagpur, P
Slide 12: Stores Added In Last Quarter
Results Update 151 Stores Added In Last Quarter Q3 FY22 Openings Q3 FY22 Closures Q3 FY22 Closure Reasons 3.2 We opened 183 183 32 4 stores in Q3FY22. stores stores There were 32 closures 9 19 4.1 9.4 Relocation Franchisee withdrawn Others 1. Stores in Puducherry are not represented in the maps abov
Slide 13: Young Store Network: 25% Less Than Months Old
Results Update Young Store Network: 25% Less Than 12 Months Old Pharmacy: Count Pharmacy: Age Structure of Stores1 Stores 1,940 2,081 2,165 2,326 2,477 14% 18% 21% Openings 2,500 24% 25% 151 Maintaining an 161 13% 12% increasing pace of 84 10% 141 10% store openings 2,000 11% 95 1,500 2,326 2,081 2,
Slide 14: Profitable Older Stores: 12+ Months
Results Update Profitable Older Stores: 12+ Months Store Level Revenue Growth1 Store Level EBITDA Margin Store Level Operating ROCE2,3 89.2% 12.4% 28.3% 10.5% 72.0% 74.0% 10.1% 10.0% 68.8% 68.8% 9.7% 5.3% 4.2% 2.8% -7.1% 1. Growth is yoy 2. See Glossary for definition 3. Annualized by multiplying th
Slide 15: Revenue Mix: Increasing Share Of Private Label
Results Update Revenue Mix: Increasing Share Of Private Label Revenue Mix: By Product Category Revenue Mix3: By Location of Stores 3.8% 2.8% 2.6% 6.1% 2.5% 6% Product mix 6% 7% 7% 8% 10.0% 9.9% 12.0% 14.6% 11.1% Trend of 20% 20% 21% 21% increasing share 11.7% 11.3% 11.4% 21% from Private 11.3% 10.9%
Slide 16: Omni-channel: Profitable With Negligible Acquisition Costs
Results Update Omni-channel: Profitable With Negligible Acquisition Costs Channel Revenue Channel Delivery Pincodes1 and Delivery Hubs 1,000 10.0% 100% Hubs 174 217 292 352 377 Home Delivery Omni-Channel 900 864 9.0% Our online 800 8.0% 80% 1,578 1,571 1,556 presence grows 725 724 693 1,394 1,426 on
Slide 17: Income Statement
Results Update Income Statement Snapshot of Income Statement, ₹m Q3FY22 vs. 9mFY22 vs. Q3FY21 Q2FY22 Q3FY22 9m FY21 9m FY22 Q3FY21 (yoy) 9mFY21 (yoy) Revenue 8,009.9 9,247.4 9,334.5 16.5% 22,635.4 28,133.7 24.3% Gross Margin 1,611.6 1,856.9 1,938.1 20.3% 4,792.3 5,910.1 23.3% Gross Margin 20.1% 20.1
Slide 18: Balance Sheet
Results Update Balance Sheet Snapshot of Balance Sheet, ₹m Dec-20 Mar-21 Sep-21 Dec-21 Assets Non Current Assets PPE and CWIP 713.5 926.9 1,152.0 1,326.5 Intangible assets 455.8 452.7 466.4 477.2 Right-of-use asset 3,605.6 3,848.7 4,643.1 4,907.6 Others 1,264.8 1,197.4 1,326.2 1,399.5 Total Non Curr
Slide 19: Capital Productivity
Results Update Capital Productivity Working Capital Cycle, days ROCE2: Operating EBIT/ Avg. Capital Employed NWC (days) 60 68 57 59 62 36.0% 45 45 43 43 Year 1 Stores 40 85 days inventory 24.7% 39 40 39 (on Year 1 stores 37 38 revenue) 19.9% 16.9% 15.8% Stores Older 24 23 22 Than 12 months 21 17 38
Slide 20: Cash Management
Results Update Cash Management Cash Management, Q3FY22, ₹m Free Cash Flow ₹ -343m Operating Cash Flow ₹ 275m PBT+ Inc. in Taxes Capex Payment Proceeds Interest Interest IPO Increase D&A+ Int. Working of lease from bank received paid Proceeds in cash of Lease Capital liabilities deposits (Net) and ca
Slide 21: Appendix
Appendix A. Board and key management B. Glossary 19
Slide 22: A. Board and Key Management
A. Board and Key Management Appendix Committed Board Experienced Management Team Gangadi Madhukar Reddy Anish Kumar Saraf Atul Gupta Dr. Bhaskar Reddy Dr. Surendranath Mantena Hemanth Kundavaram Founded MedPlus and has MD at Warburg Pincus Investment partner at COO–Outlet Operations COO–MedPlus Mart
Slide 23: B. Glossary
B. Glossary Appendix Term Description Metro: Bengaluru, Chennai (and Avadi), Hyderabad, Kolkata (and Howrah), Mumbai (and Thane) City Categorization Tier One: Ahmednagar, Baramati, Kharagpur, Nagpur, Nashik, Panruti, Pune, Ranaghat, Vijayawada, Visakhapatnam (internal) Tier Two: Ninety-five cities,
Slide 24: MedPlus Health Services Limited
MEDPLUS HEALTH SERVICES LIMITED www.medplusindia.com COMPANY SECRETARY Shilpi Keswani cs@medplusindia.com INVESTOR RELATIONS Prasad Reddy/ Tanushree Chaurasia ir@medplusindia.com MEDIA AND PRESS ENQUIRIES marketing@medplusindia.com
MedPlus Health Services — Q3 FY2022 Earnings Presentation on 6ix